Video
Patricia Coyle from Stony Brook University: Moving Care of Progressive Multiple Sclerosis Forward
Author(s):
As the treatment of relapsing remitting multiple sclerosis continues to add new treatment methods patients with progressive forms of the condition are still waiting for their first approved medication to manage their symptoms.
As the treatment of relapsing remitting multiple sclerosis continues to add new treatment methods patients with progressive forms of the condition are still waiting for their first approved medication to manage their symptoms.
Patricia K. Coyle, MD, from Stony Brook Medicine discussed developments made in the treatment of progressive forms of multiple sclerosis during the annual meeting of the Consortium of Multiple Sclerosis Centers. While the US Food and Drug Administration has not yet approved any treatments for the progressive form of the disease there are several drugs in the pipeline and one, Ocrelizumab, which is nearing the completion of the approval process.
Real-World Study Confirms Similar Efficacy of Guselkumab and IL-17i for PsA
